View in EDS HTML Full Text PDF Full Text

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.

Saved in:
Bibliographic Details
Title: Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Authors: Kos Z; Department of Pathology, BC Cancer - Vancouver, Vancouver, BC Canada., Roblin E; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France., Kim RS; 4National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA USA., Michiels S; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France., Gallas BD; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA., Chen W; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA., van de Vijver KK; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.; 7Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium., Goel S; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia., Adams S; 10Perlmutter Cancer Center, New York University Medical School, New York, NY USA., Demaria S; 11Departments of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY USA., Viale G; 12Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy., Nielsen TO; 13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada., Badve SS; 14Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA., Symmans WF; 15Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX USA., Sotiriou C; 16Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Rimm DL; 17Department of Pathology, Yale School of Medicine, New Haven, CT USA., Hewitt S; 18Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD USA., Denkert C; 19Institute of Pathology, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg and Philipps-Universität Marburg, Marburg, Germany., Loibl S; 20German Breast Group, Neu-Isenburg, Germany., Luen SJ; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia., Bartlett JMS; 22Ontario Institute for Cancer Research, Toronto, ON Canada.; 23University of Edinburgh Cancer Research Centre, Edinburgh, UK., Savas P; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia., Pruneri G; 24Department of Pathology, IRCCS Fondazione Instituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy., Dillon DA; 25Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.; 26Department of Pathology, Dana Farber Cancer Institute, Boston, MA USA., Cheang MCU; 27Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, UK., Tutt A; 28Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Hall JA; Vivactiv Ltd, Bellingdon, Bucks, UK., Kok M; 30Department of Medical Oncology and Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.; 31Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Madabhushi A; 32Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH USA.; 33Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH USA., van der Laak J; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Ciompi F; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Laenkholm AV; 35Department of Surgical Pathology Zealand University Hospital, Køge, Denmark., Bellolio E; 36Departamento de Anatomía Patológica, Universidad de La Frontera, Temuco, Chile., Gruosso T; Forbius, Montreal, QC Canada., Fox SB; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.; 38Department of Pathology, Peter MacCallum Cancer Centre Department of Pathology, Melbourne, VIC Australia., Araya JC; 39Department of Pathology, Universidad de la Frontera, Temuco, Chile., Floris G; 40KU Leuven- Univerisity of Leuven, Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and KU Leuven- University Hospitals Leuven, Department of Pathology, Leuven, Belgium., Hudeček J; 41Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Voorwerk L; 42Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beck AH; 43PathAI, Inc, Boston, MA USA., Kerner J; 43PathAI, Inc, Boston, MA USA., Larsimont D; 44Department of Pathology, Jules Bordet Institute, Brussels, Belgium., Declercq S; Department of Pathology, GZA-ZNA, Antwerp, Belgium., Van den Eynden G; Department of Pathology, GZA-ZNA, Antwerp, Belgium., Pusztai L; 46Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT USA., Ehinger A; 47Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, Lund, Sweden., Yang W; 48Department of Pathology, Fudan University Shanghai Cancer Centre, Shanghai, China., AbdulJabbar K; 49Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Yuan Y; 49Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Singh R; 50Icahn School of Medicine at Mt. Sinai, New York, NY 10029 USA., Hiley C; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK., Bakir MA; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK., Lazar AJ; 52Departments of Pathology, Genomic Medicine, Dermatology, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Naber S; 53Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, USA., Wienert S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany., Castillo M; 55Department of Medical Oncology and Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038 Peru., Curigliano G; 56University of Milan, Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Dieci MV; 57Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.; 58Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., André F; 59Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Swanton C; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; 60Francis Crick Institute, Midland Road, London, UK., Reis-Filho J; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.; 62Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY USA., Sparano J; 63Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY USA., Balslev E; 64Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark., Chen IC; 65Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; 66Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; 67Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan., Stovgaard EIS; 64Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark., Pogue-Geile K; 4National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA USA., Blenman KRM; 46Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT USA., Penault-Llorca F; 68Centre de Lutte contre le cancer - Centre Jean Perrin, Clermont-Ferrand, France., Schnitt S; 25Department of Pathology, Brigham and Women's Hospital, Boston, MA USA., Lakhani SR; 69The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, QLD Australia., Vincent-Salomon A; Institut Curie, Paris Sciences Lettres Université, Inserm U934, Department of Pathology, Paris, France., Rojo F; 71Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) - CIBERONC, Madrid, Spain.; 72GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Braybrooke JP; 73Nuffield Department of Population Health, University of Oxford, Oxford and Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Hanna MG; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA., Soler-Monsó MT; 74Department of Pathology, Bellvitge University Hospital, IDIBELL. Breast Unit. Catalan Institut of Oncology. L 'Hospitalet del Llobregat', Barcelona, 08908 Catalonia Spain., Bethmann D; 75University Hospital Halle (Saale), Institute of Pathology, Halle (Saale), Germany., Castaneda CA; 55Department of Medical Oncology and Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038 Peru., Willard-Gallo K; 76Molecular Immunology Unit, Institut Jules Bordet, Universitè Libre de Bruxelles, Brussels, Belgium., Sharma A; 77Department of Biomedical Informatics, Emory University, Atlanta, GA USA., Lien HC; 78Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Fineberg S; 79Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY USA., Thagaard J; 80DTU Compute, Department of Applied Mathematics, Technical University of Denmark; Visiopharm A/S, Hørsholm, Denmark., Comerma L; 72GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.; 81Pathology Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain., Gonzalez-Ericsson P; 82Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN USA., Brogi E; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA., Loi S; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia., Saltz J; 83Biomedical Informatics Department, Stony Brook University, Stony Brook, NY USA., Klaushen F; 84Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Cooper L; 85Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL USA., Amgad M; 86Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA., Moore DA; 87Department of Pathology, UCL Cancer Institute, UCL, London, UK.; 88University College Hospitals NHS Trust, London, UK., Salgado R; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.; Department of Pathology, GZA-ZNA, Antwerp, Belgium.
Corporate Authors: International Immuno-Oncology Biomarker Working Group
Source: NPJ breast cancer [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 17. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32411819
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kos+Z%22">Kos Z</searchLink>; Department of Pathology, BC Cancer - Vancouver, Vancouver, BC Canada.<br /><searchLink fieldCode="AU" term="%22Roblin+E%22">Roblin E</searchLink>; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Kim+RS%22">Kim RS</searchLink>; 4National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA USA.<br /><searchLink fieldCode="AU" term="%22Michiels+S%22">Michiels S</searchLink>; 2Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France.; 3Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Gallas+BD%22">Gallas BD</searchLink>; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; 5Division of Imaging, Diagnostics, and Software Reliability (DIDSR); Office of Science and Engineering Laboratories (OSEL); Center for Devices and Radiological Health (CDRH), US Food and Drug Administration (US FDA), Silver Spring, MD USA.<br /><searchLink fieldCode="AU" term="%22van+de+Vijver+KK%22">van de Vijver KK</searchLink>; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.; 7Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.<br /><searchLink fieldCode="AU" term="%22Goel+S%22">Goel S</searchLink>; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.<br /><searchLink fieldCode="AU" term="%22Adams+S%22">Adams S</searchLink>; 10Perlmutter Cancer Center, New York University Medical School, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Demaria+S%22">Demaria S</searchLink>; 11Departments of Radiation Oncology and Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Viale+G%22">Viale G</searchLink>; 12Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Nielsen+TO%22">Nielsen TO</searchLink>; 13Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Badve+SS%22">Badve SS</searchLink>; 14Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; 15Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX USA.<br /><searchLink fieldCode="AU" term="%22Sotiriou+C%22">Sotiriou C</searchLink>; 16Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Rimm+DL%22">Rimm DL</searchLink>; 17Department of Pathology, Yale School of Medicine, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Hewitt+S%22">Hewitt S</searchLink>; 18Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD USA.<br /><searchLink fieldCode="AU" term="%22Denkert+C%22">Denkert C</searchLink>; 19Institute of Pathology, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg and Philipps-Universität Marburg, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Loibl+S%22">Loibl S</searchLink>; 20German Breast Group, Neu-Isenburg, Germany.<br /><searchLink fieldCode="AU" term="%22Luen+SJ%22">Luen SJ</searchLink>; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.<br /><searchLink fieldCode="AU" term="%22Bartlett+JMS%22">Bartlett JMS</searchLink>; 22Ontario Institute for Cancer Research, Toronto, ON Canada.; 23University of Edinburgh Cancer Research Centre, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Savas+P%22">Savas P</searchLink>; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.<br /><searchLink fieldCode="AU" term="%22Pruneri+G%22">Pruneri G</searchLink>; 24Department of Pathology, IRCCS Fondazione Instituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Dillon+DA%22">Dillon DA</searchLink>; 25Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.; 26Department of Pathology, Dana Farber Cancer Institute, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Cheang+MCU%22">Cheang MCU</searchLink>; 27Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Tutt+A%22">Tutt A</searchLink>; 28Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Hall+JA%22">Hall JA</searchLink>; Vivactiv Ltd, Bellingdon, Bucks, UK.<br /><searchLink fieldCode="AU" term="%22Kok+M%22">Kok M</searchLink>; 30Department of Medical Oncology and Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Horlings+HM%22">Horlings HM</searchLink>; 6Department of Pathology, University Hospital Antwerp, Antwerp, Belgium.; 31Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Madabhushi+A%22">Madabhushi A</searchLink>; 32Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH USA.; 33Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH USA.<br /><searchLink fieldCode="AU" term="%22van+der+Laak+J%22">van der Laak J</searchLink>; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Ciompi+F%22">Ciompi F</searchLink>; 34Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands.<br /><searchLink fieldCode="AU" term="%22Laenkholm+AV%22">Laenkholm AV</searchLink>; 35Department of Surgical Pathology Zealand University Hospital, Køge, Denmark.<br /><searchLink fieldCode="AU" term="%22Bellolio+E%22">Bellolio E</searchLink>; 36Departamento de Anatomía Patológica, Universidad de La Frontera, Temuco, Chile.<br /><searchLink fieldCode="AU" term="%22Gruosso+T%22">Gruosso T</searchLink>; Forbius, Montreal, QC Canada.<br /><searchLink fieldCode="AU" term="%22Fox+SB%22">Fox SB</searchLink>; 8The Sir Peter MacCallum Cancer Centre, Melbourne, VIC Australia.; 38Department of Pathology, Peter MacCallum Cancer Centre Department of Pathology, Melbourne, VIC Australia.<br /><searchLink fieldCode="AU" term="%22Araya+JC%22">Araya JC</searchLink>; 39Department of Pathology, Universidad de la Frontera, Temuco, Chile.<br /><searchLink fieldCode="AU" term="%22Floris+G%22">Floris G</searchLink>; 40KU Leuven- Univerisity of Leuven, Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and KU Leuven- University Hospitals Leuven, Department of Pathology, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hudeček+J%22">Hudeček J</searchLink>; 41Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Voorwerk+L%22">Voorwerk L</searchLink>; 42Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Beck+AH%22">Beck AH</searchLink>; 43PathAI, Inc, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Kerner+J%22">Kerner J</searchLink>; 43PathAI, Inc, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Larsimont+D%22">Larsimont D</searchLink>; 44Department of Pathology, Jules Bordet Institute, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Declercq+S%22">Declercq S</searchLink>; Department of Pathology, GZA-ZNA, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Van+den+Eynden+G%22">Van den Eynden G</searchLink>; Department of Pathology, GZA-ZNA, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Pusztai+L%22">Pusztai L</searchLink>; 46Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Ehinger+A%22">Ehinger A</searchLink>; 47Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Yang+W%22">Yang W</searchLink>; 48Department of Pathology, Fudan University Shanghai Cancer Centre, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22AbdulJabbar+K%22">AbdulJabbar K</searchLink>; 49Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Yuan+Y%22">Yuan Y</searchLink>; 49Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; 50Icahn School of Medicine at Mt. Sinai, New York, NY 10029 USA.<br /><searchLink fieldCode="AU" term="%22Hiley+C%22">Hiley C</searchLink>; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Bakir+MA%22">Bakir MA</searchLink>; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lazar+AJ%22">Lazar AJ</searchLink>; 52Departments of Pathology, Genomic Medicine, Dermatology, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.<br /><searchLink fieldCode="AU" term="%22Naber+S%22">Naber S</searchLink>; 53Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Wienert+S%22">Wienert S</searchLink>; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Castillo+M%22">Castillo M</searchLink>; 55Department of Medical Oncology and Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038 Peru.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; 56University of Milan, Istituto Europeo di Oncologia, IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Dieci+MV%22">Dieci MV</searchLink>; 57Medical Oncology 2, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.; 58Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22André+F%22">André F</searchLink>; 59Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; 51Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; 60Francis Crick Institute, Midland Road, London, UK.<br /><searchLink fieldCode="AU" term="%22Reis-Filho+J%22">Reis-Filho J</searchLink>; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.; 62Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Sparano+J%22">Sparano J</searchLink>; 63Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY USA.<br /><searchLink fieldCode="AU" term="%22Balslev+E%22">Balslev E</searchLink>; 64Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Chen+IC%22">Chen IC</searchLink>; 65Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.; 66Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; 67Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Stovgaard+EIS%22">Stovgaard EIS</searchLink>; 64Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Pogue-Geile+K%22">Pogue-Geile K</searchLink>; 4National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA USA.<br /><searchLink fieldCode="AU" term="%22Blenman+KRM%22">Blenman KRM</searchLink>; 46Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT USA.<br /><searchLink fieldCode="AU" term="%22Penault-Llorca+F%22">Penault-Llorca F</searchLink>; 68Centre de Lutte contre le cancer - Centre Jean Perrin, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Schnitt+S%22">Schnitt S</searchLink>; 25Department of Pathology, Brigham and Women's Hospital, Boston, MA USA.<br /><searchLink fieldCode="AU" term="%22Lakhani+SR%22">Lakhani SR</searchLink>; 69The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, QLD Australia.<br /><searchLink fieldCode="AU" term="%22Vincent-Salomon+A%22">Vincent-Salomon A</searchLink>; Institut Curie, Paris Sciences Lettres Université, Inserm U934, Department of Pathology, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rojo+F%22">Rojo F</searchLink>; 71Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) - CIBERONC, Madrid, Spain.; 72GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Braybrooke+JP%22">Braybrooke JP</searchLink>; 73Nuffield Department of Population Health, University of Oxford, Oxford and Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Hanna+MG%22">Hanna MG</searchLink>; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Soler-Monsó+MT%22">Soler-Monsó MT</searchLink>; 74Department of Pathology, Bellvitge University Hospital, IDIBELL. Breast Unit. Catalan Institut of Oncology. L 'Hospitalet del Llobregat', Barcelona, 08908 Catalonia Spain.<br /><searchLink fieldCode="AU" term="%22Bethmann+D%22">Bethmann D</searchLink>; 75University Hospital Halle (Saale), Institute of Pathology, Halle (Saale), Germany.<br /><searchLink fieldCode="AU" term="%22Castaneda+CA%22">Castaneda CA</searchLink>; 55Department of Medical Oncology and Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, 15038 Peru.<br /><searchLink fieldCode="AU" term="%22Willard-Gallo+K%22">Willard-Gallo K</searchLink>; 76Molecular Immunology Unit, Institut Jules Bordet, Universitè Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink>; 77Department of Biomedical Informatics, Emory University, Atlanta, GA USA.<br /><searchLink fieldCode="AU" term="%22Lien+HC%22">Lien HC</searchLink>; 78Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Fineberg+S%22">Fineberg S</searchLink>; 79Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY USA.<br /><searchLink fieldCode="AU" term="%22Thagaard+J%22">Thagaard J</searchLink>; 80DTU Compute, Department of Applied Mathematics, Technical University of Denmark; Visiopharm A/S, Hørsholm, Denmark.<br /><searchLink fieldCode="AU" term="%22Comerma+L%22">Comerma L</searchLink>; 72GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain.; 81Pathology Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Ericsson+P%22">Gonzalez-Ericsson P</searchLink>; 82Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN USA.<br /><searchLink fieldCode="AU" term="%22Brogi+E%22">Brogi E</searchLink>; 61Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; 9Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria Australia.; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.<br /><searchLink fieldCode="AU" term="%22Saltz+J%22">Saltz J</searchLink>; 83Biomedical Informatics Department, Stony Brook University, Stony Brook, NY USA.<br /><searchLink fieldCode="AU" term="%22Klaushen+F%22">Klaushen F</searchLink>; 84Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Cooper+L%22">Cooper L</searchLink>; 85Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL USA.<br /><searchLink fieldCode="AU" term="%22Amgad+M%22">Amgad M</searchLink>; 86Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA.<br /><searchLink fieldCode="AU" term="%22Moore+DA%22">Moore DA</searchLink>; 87Department of Pathology, UCL Cancer Institute, UCL, London, UK.; 88University College Hospitals NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Salgado+R%22">Salgado R</searchLink>; 21Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC Australia.; Department of Pathology, GZA-ZNA, Antwerp, Belgium.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22International+Immuno-Oncology+Biomarker+Working+Group%22">International Immuno-Oncology Biomarker Working Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 17. <i>Date of Electronic Publication: </i>2020 May 12 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32411819
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-020-0156-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17
    Titles:
      – TitleFull: Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kos Z
      – PersonEntity:
          Name:
            NameFull: Roblin E
      – PersonEntity:
          Name:
            NameFull: Kim RS
      – PersonEntity:
          Name:
            NameFull: Michiels S
      – PersonEntity:
          Name:
            NameFull: Gallas BD
      – PersonEntity:
          Name:
            NameFull: Chen W
      – PersonEntity:
          Name:
            NameFull: van de Vijver KK
      – PersonEntity:
          Name:
            NameFull: Goel S
      – PersonEntity:
          Name:
            NameFull: Adams S
      – PersonEntity:
          Name:
            NameFull: Demaria S
      – PersonEntity:
          Name:
            NameFull: Viale G
      – PersonEntity:
          Name:
            NameFull: Nielsen TO
      – PersonEntity:
          Name:
            NameFull: Badve SS
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Sotiriou C
      – PersonEntity:
          Name:
            NameFull: Rimm DL
      – PersonEntity:
          Name:
            NameFull: Hewitt S
      – PersonEntity:
          Name:
            NameFull: Denkert C
      – PersonEntity:
          Name:
            NameFull: Loibl S
      – PersonEntity:
          Name:
            NameFull: Luen SJ
      – PersonEntity:
          Name:
            NameFull: Bartlett JMS
      – PersonEntity:
          Name:
            NameFull: Savas P
      – PersonEntity:
          Name:
            NameFull: Pruneri G
      – PersonEntity:
          Name:
            NameFull: Dillon DA
      – PersonEntity:
          Name:
            NameFull: Cheang MCU
      – PersonEntity:
          Name:
            NameFull: Tutt A
      – PersonEntity:
          Name:
            NameFull: Hall JA
      – PersonEntity:
          Name:
            NameFull: Kok M
      – PersonEntity:
          Name:
            NameFull: Horlings HM
      – PersonEntity:
          Name:
            NameFull: Madabhushi A
      – PersonEntity:
          Name:
            NameFull: van der Laak J
      – PersonEntity:
          Name:
            NameFull: Ciompi F
      – PersonEntity:
          Name:
            NameFull: Laenkholm AV
      – PersonEntity:
          Name:
            NameFull: Bellolio E
      – PersonEntity:
          Name:
            NameFull: Gruosso T
      – PersonEntity:
          Name:
            NameFull: Fox SB
      – PersonEntity:
          Name:
            NameFull: Araya JC
      – PersonEntity:
          Name:
            NameFull: Floris G
      – PersonEntity:
          Name:
            NameFull: Hudeček J
      – PersonEntity:
          Name:
            NameFull: Voorwerk L
      – PersonEntity:
          Name:
            NameFull: Beck AH
      – PersonEntity:
          Name:
            NameFull: Kerner J
      – PersonEntity:
          Name:
            NameFull: Larsimont D
      – PersonEntity:
          Name:
            NameFull: Declercq S
      – PersonEntity:
          Name:
            NameFull: Van den Eynden G
      – PersonEntity:
          Name:
            NameFull: Pusztai L
      – PersonEntity:
          Name:
            NameFull: Ehinger A
      – PersonEntity:
          Name:
            NameFull: Yang W
      – PersonEntity:
          Name:
            NameFull: AbdulJabbar K
      – PersonEntity:
          Name:
            NameFull: Yuan Y
      – PersonEntity:
          Name:
            NameFull: Singh R
      – PersonEntity:
          Name:
            NameFull: Hiley C
      – PersonEntity:
          Name:
            NameFull: Bakir MA
      – PersonEntity:
          Name:
            NameFull: Lazar AJ
      – PersonEntity:
          Name:
            NameFull: Naber S
      – PersonEntity:
          Name:
            NameFull: Wienert S
      – PersonEntity:
          Name:
            NameFull: Castillo M
      – PersonEntity:
          Name:
            NameFull: Curigliano G
      – PersonEntity:
          Name:
            NameFull: Dieci MV
      – PersonEntity:
          Name:
            NameFull: André F
      – PersonEntity:
          Name:
            NameFull: Swanton C
      – PersonEntity:
          Name:
            NameFull: Reis-Filho J
      – PersonEntity:
          Name:
            NameFull: Sparano J
      – PersonEntity:
          Name:
            NameFull: Balslev E
      – PersonEntity:
          Name:
            NameFull: Chen IC
      – PersonEntity:
          Name:
            NameFull: Stovgaard EIS
      – PersonEntity:
          Name:
            NameFull: Pogue-Geile K
      – PersonEntity:
          Name:
            NameFull: Blenman KRM
      – PersonEntity:
          Name:
            NameFull: Penault-Llorca F
      – PersonEntity:
          Name:
            NameFull: Schnitt S
      – PersonEntity:
          Name:
            NameFull: Lakhani SR
      – PersonEntity:
          Name:
            NameFull: Vincent-Salomon A
      – PersonEntity:
          Name:
            NameFull: Rojo F
      – PersonEntity:
          Name:
            NameFull: Braybrooke JP
      – PersonEntity:
          Name:
            NameFull: Hanna MG
      – PersonEntity:
          Name:
            NameFull: Soler-Monsó MT
      – PersonEntity:
          Name:
            NameFull: Bethmann D
      – PersonEntity:
          Name:
            NameFull: Castaneda CA
      – PersonEntity:
          Name:
            NameFull: Willard-Gallo K
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Lien HC
      – PersonEntity:
          Name:
            NameFull: Fineberg S
      – PersonEntity:
          Name:
            NameFull: Thagaard J
      – PersonEntity:
          Name:
            NameFull: Comerma L
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Ericsson P
      – PersonEntity:
          Name:
            NameFull: Brogi E
      – PersonEntity:
          Name:
            NameFull: Loi S
      – PersonEntity:
          Name:
            NameFull: Saltz J
      – PersonEntity:
          Name:
            NameFull: Klaushen F
      – PersonEntity:
          Name:
            NameFull: Cooper L
      – PersonEntity:
          Name:
            NameFull: Amgad M
      – PersonEntity:
          Name:
            NameFull: Moore DA
      – PersonEntity:
          Name:
            NameFull: Salgado R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2020 May 12
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 6
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1